Swiggy shares fall another 2% to hit new low. Will it hit Macquarie target price of Rs 325?
The stock dropped below its IPO price of Rs 390 in the previous session, ending the day with a 7% loss. Although revenue rose ...
Labcorp's Narrow Economic Moat Remains Solid
The more complex and labor-intensive esoteric tests are reimbursed at a higher rate and often outsourced by hospitals to independent labs. Labcorp is funneling resources to broaden its menu of complex ...
FiercePharma9h
Regeneron tangles with Sanofi over commercial transparency in long-running Dupixent collaboration
Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...